BCLS II Investco, LP's Net Worth

$0

Estimate Recalculated Nov 1, 2024 05:19AM EST

Who is BCLS II Investco, LP?

BCLS II Investco, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Xilio Therapeutics, Inc., Solid Biosciences Inc., and NewAmsterdam Pharma Co N.V..

SEC CIK

BCLS II Investco, LP's CIK is 0001818893

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.54%
42.47K
$9.66
$410,161.39
2.81M
Dec 8 - Dec 10
Form 3
—
0
—
—
0
No matching records found

Solid Biosciences Inc. (SLDB) Snapshot price: $8.11

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+28.88%
904.16K
$5.53
$5,000,004.80
4.03M
Jan 11
Form 3
—
0
—
—
0
No matching records found

NewAmsterdam Pharma Co N.V. (NAMS) Snapshot price: $16.4

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found